Announcement Summary

Entity name

CRESO PHARMA LIMITED

Announcement Type New announcement

Date of this announcement Friday April 01, 2022

Details of +securities that have ceasedASX +security codeSecurity descriptionNumber of +securities that The +securities have have ceased ceased due to

Date of cessation

CPHAV

OPTION EXPIRING 10-MAR-2024 EX 8C

333,334 Lapse of conditional right to 31/03/2022 securities because the conditions have not been, or have become incapable of being, satisfied

CPHAW

OPTION EXPIRING 10-MAR-2024 EX 16C

333,334 Lapse of conditional right to 31/03/2022 securities because the conditions have not been, or have become incapable of being, satisfied

CPHAX

OPTION EXPIRING 10-MAR-2024 EX 20CRefer to next page for full details of the announcement

166,667 Lapse of conditional right to 31/03/2022 securities because the conditions have not been, or have become incapable of being, satisfied

Part 1 - Announcement Details

1.1 Name of +Entity CRESO PHARMA LIMITED

We (the entity named above) provide the following information about our issued capital.

1.2 Registered Number Type ABN

1.3 ASX issuer code CPH

1.4 The announcement isNew announcement

1.5 Date of this announcement 1/4/2022

Registration Number 89609406911

Part 2 - Details of +equity securities or +debt securities that have ceased

ASX +Security Code and Description

CPHAV : OPTION EXPIRING 10-MAR-2024 EX 8C

Unquoted +equity securities that have ceased

Number of securities that have ceased 333,334

Reason for cessation

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

Date of cessation 31/3/2022

Is the entity paying any consideration for the cessation?

No

Any other information the entity wishes to notify to ASX about the cessation?

N/A

ASX +Security Code and Description

CPHAW : OPTION EXPIRING 10-MAR-2024 EX 16C

Unquoted +equity securities that have ceased

Number of securities that have ceased 333,334

Reason for cessation

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

Date of cessation 31/3/2022

Is the entity paying any consideration for the cessation?

No

Any other information the entity wishes to notify to ASX about the cessation?

N/A

ASX +Security Code and Description

CPHAX : OPTION EXPIRING 10-MAR-2024 EX 20C

Unquoted +equity securities that have ceased

Number of securities that have ceased

Number of securities that have ceased 166,667

Reason for cessation

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

onlyFor personal use

Date of cessation 31/3/2022

Is the entity paying any consideration for the cessation?

No

Any other information the entity wishes to notify to ASX about the cessation?

N/A

Part 3 - Issued capital following changes

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)Total number of

ASX +security code and description

+securities on issue

CPHOA : OPTION EXPIRING 22-JAN-2023

63,958,997

CPH : ORDINARY FULLY PAID

1,296,092,502

CPHO : OPTION EXPIRING 02-NOV-2024

400,942,239

3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)ASX +security code and descriptionTotal number of

+securities on issue

CPHAAN : OPTION EXPIRING 06-SEP-2024 EX $0.25 10,000,000

CPHAAO : PERFORMANCE RIGHTS 15,000,000

CPHAY : OPTION EXPIRING 02-JUN-2023 EX 17C 27,764,706

CPHAAA : OPTION EXPIRING 02-JUN-2023 EX 20C 8,000,000

CPHAZ : OPTION EXPIRING 02-JUN-2023 EX 25C 4,000,000

CPHAQ : OPTION EXPIRING 15-SEP-2022 EX 80C

300,000

CPHAAB : OPTION EXPIRING 25-JUN-2023 EX 13.86C 5,752,688

CPHAAL : OPTION EXPIRING 01-AUG-2024 EX $0.18 12,000,000

CPHAS : OPTION EXPIRING 12-FEB-2023 EX 40C 6,847,725

CPHAT : OPTION EXPIRING 12-FEB-2023 EX 35C 2,128,387

CPHAAK : OPTION EXPIRING 01-AUG-2024 EX $0.15 12,000,000

CPHAAM : OPTION EXPIRING 06-SEP-2024 EX $0.18 10,000,000

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Creso Pharma Ltd. published this content on 01 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 April 2022 06:12:04 UTC.